Does TOCILIZUMAB Cause Hypercholesterolaemia? 1,483 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,483 reports of Hypercholesterolaemia have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 1.5% of all adverse event reports for TOCILIZUMAB.
1,483
Reports of Hypercholesterolaemia with TOCILIZUMAB
1.5%
of all TOCILIZUMAB reports
1,213
Deaths
924
Hospitalizations
How Dangerous Is Hypercholesterolaemia From TOCILIZUMAB?
Of the 1,483 reports, 1,213 (81.8%) resulted in death, 924 (62.3%) required hospitalization, and 903 (60.9%) were considered life-threatening.
Is Hypercholesterolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 1,483 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Hypercholesterolaemia?
ALENDRONATE (1,607)
METHOTREXATE (1,547)
ADALIMUMAB (1,479)
ABATACEPT (1,410)
RITUXIMAB (1,389)
PREDNISONE (1,377)
INFLIXIMAB (1,338)
DICLOFENAC (1,331)
LEFLUNOMIDE (1,322)
CERTOLIZUMAB PEGOL (1,321)
Which TOCILIZUMAB Alternatives Have Lower Hypercholesterolaemia Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE